Baricitinib

CHEMBL2105759 Phase 4 अनुमोदित Small molecule
Half-Life
12 hours
Bioavailability
Protein Binding
Molecular Weight
371.4 g/mol
LogP
-0.5
Phase
4

A JAK1/JAK2 inhibitor that blocks the intracellular signaling pathways that drive inflammation in conditions such as rheumatoid arthritis and atopic dermatitis. It is taken by mouth once daily.

आणविक भार

371.4170 g/mol

LogP

-0.50

TPSA

129.00 Ų

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

दवा वर्ग

क्रिया का तंत्र

Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Pharmacokinetics (PK)

Half-Life 12 hours

Pharmacodynamics (PD)

तंत्र

Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1

InChI

InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)

Molecular Formula

C16H17N7O2S

HBD / HBA

1 / 7

घूर्णनीय बंधन

5

भारी परमाणु

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

A JAK1/JAK2 inhibitor that blocks the intracellular signaling pathways that drive inflammation in conditions such as rheumatoid arthritis and atopic dermatitis. It is taken by mouth once daily.

Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Key pharmacokinetic parameters for Baricitinib: Half-life: 12 hours.

Yes, Baricitinib is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105759. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 44205240. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.